Boehringer, Forma Strike Discovery Deal In Oncology
By
Paul Bonanos / Email the Author / “The Pink Sheet” DAILY Jan. 5, 2012
Word Count: 817 / Article # 14120105001
Executive Summary
The German pharma pays $65 million upfront in a deal with high-ceilinged milestones, in an ambitious effort to discover cancer drugs that affect protein-protein interactions.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.